Case study on the use of intensive pediatric neurorehabilitation in the treatment of kernicterus.
Intensive pediatric Neurorehabilitation
Kernicterus
Kernicterus Spectrum disorder
Journal
Journal of clinical movement disorders
ISSN: 2054-7072
Titre abrégé: J Clin Mov Disord
Pays: England
ID NLM: 101662043
Informations de publication
Date de publication:
2020
2020
Historique:
received:
30
10
2019
accepted:
29
01
2020
entrez:
12
2
2020
pubmed:
12
2
2020
medline:
12
2
2020
Statut:
epublish
Résumé
Kernicterus Spectrum Disorder (KSD) is the result of prolonged bilirubin toxicity resulting in widespread neurological injury. Once the bilirubin levels are normalized the encephalopathy becomes static, however the consequences of the injury can have life-long effects. The sequelae of KSD include motor impairments, auditory deficits, dental dysplasia, and potentially cognitive impairments. While KSD is a rare diagnosis, particularly in developed countries, there is evidence that there may be a global increase in incidence (Hansen, Semin Neonatol 7:103-9, 2002; Johnson, J Perinatol 29:S25-45, 2009; Kaplan etal. Neonatology 100:354-62, 2011; Maisels, Early Hum Dev 85:727-32, 2009; Olusanya etal., Arch Dis Child 99:1117-21, 2014; Steffensrud, Newborn Infant Nurs Rev 4:191-200, 2004). The literature on the treatment of various specific sequelae of KSD is varied, but in general specific therapeutic efforts to improve motor skills are not evidenced-based. The following is a case report on the use of Acquire therapy, an intensive neuromotor intervention, to ameliorate some of the motor-function deficits secondary to KSD. This case-report presents the results of two intensive therapeutic intervention sessions in one male child with KSD. Treatments occurred at 28 and 34 months. The child presented with fine and gross motor deficits as well as communication delays. Each session consisted of daily therapy for 4 h each weekday for 3 weeks. The child was assessed before and after treatment with 2 standardized measures, the Gross Motor Function Measure (GMFM) and The Bayley Scales of Infant and Toddler Development (Bayley). The GMFM at the 1st assessment was 34, 74at the 2nd assessment (after intervention 1), and 64 at the third assessment and 104 at the 4th assessment (after intervention 2). The Bayley at the 3rd assessment was 18, and 38 at the 4th assessment (after intervention 2).
Sections du résumé
BACKGROUND
BACKGROUND
Kernicterus Spectrum Disorder (KSD) is the result of prolonged bilirubin toxicity resulting in widespread neurological injury. Once the bilirubin levels are normalized the encephalopathy becomes static, however the consequences of the injury can have life-long effects. The sequelae of KSD include motor impairments, auditory deficits, dental dysplasia, and potentially cognitive impairments. While KSD is a rare diagnosis, particularly in developed countries, there is evidence that there may be a global increase in incidence (Hansen, Semin Neonatol 7:103-9, 2002; Johnson, J Perinatol 29:S25-45, 2009; Kaplan etal. Neonatology 100:354-62, 2011; Maisels, Early Hum Dev 85:727-32, 2009; Olusanya etal., Arch Dis Child 99:1117-21, 2014; Steffensrud, Newborn Infant Nurs Rev 4:191-200, 2004). The literature on the treatment of various specific sequelae of KSD is varied, but in general specific therapeutic efforts to improve motor skills are not evidenced-based. The following is a case report on the use of Acquire therapy, an intensive neuromotor intervention, to ameliorate some of the motor-function deficits secondary to KSD.
CASE PRESENTATION
METHODS
This case-report presents the results of two intensive therapeutic intervention sessions in one male child with KSD. Treatments occurred at 28 and 34 months. The child presented with fine and gross motor deficits as well as communication delays. Each session consisted of daily therapy for 4 h each weekday for 3 weeks. The child was assessed before and after treatment with 2 standardized measures, the Gross Motor Function Measure (GMFM) and The Bayley Scales of Infant and Toddler Development (Bayley).
CONCLUSIONS
CONCLUSIONS
The GMFM at the 1st assessment was 34, 74at the 2nd assessment (after intervention 1), and 64 at the third assessment and 104 at the 4th assessment (after intervention 2). The Bayley at the 3rd assessment was 18, and 38 at the 4th assessment (after intervention 2).
Identifiants
pubmed: 32042435
doi: 10.1186/s40734-020-0084-z
pii: 84
pmc: PMC6998181
doi:
Types de publication
Case Reports
Langues
eng
Pagination
1Informations de copyright
© The Author(s). 2020.
Déclaration de conflit d'intérêts
Competing interestsThe authors declare that they have no competing interests.
Références
J Child Neurol. 2006 Nov;21(11):931-8
pubmed: 17092457
Neonatology. 2011;100(4):354-62
pubmed: 21968213
Clin Perinatol. 2006 Jun;33(2):387-410
pubmed: 16765731
Semin Neonatol. 2002 Apr;7(2):103-9
pubmed: 12208094
Arch Dis Child. 2014 Dec;99(12):1117-21
pubmed: 25123403
J Perinatol. 2005 Jan;25(1):54-9
pubmed: 15578034
Phys Ther. 2003 Nov;83(11):1003-13
pubmed: 14577827
J Perinatol. 2010 Oct;30 Suppl:S6-15
pubmed: 20877410
J Perinatol. 2009 Feb;29 Suppl 1:S25-45
pubmed: 19177057
N Engl J Med. 2013 Nov 21;369(21):2021-30
pubmed: 24256380
Curr Pediatr Rev. 2017;13(3):199-209
pubmed: 28814249
JAMA. 2002 Sep 18;288(11):1357-63
pubmed: 12234229
Early Hum Dev. 2009 Nov;85(11):727-32
pubmed: 19833460
Am J Occup Ther. 2015 Nov-Dec;69(6):6906180010p1-9
pubmed: 26565094
J Perinatol. 2004 Oct;24(10):650-62
pubmed: 15254556
BMC Res Notes. 2017 Dec 19;10(1):743
pubmed: 29258560